Ambry Genetics and Invicro, Konica Minolta Companies
For the last 20 years, Ambry has been seeking to better understanding gene-disease relationships through collaboration, research and innovation. We have identified novel genes, designed custom assays, and brought to market more than 500 unique diagnostic tests. We’ve been first-to-market with game-changing technologies, including clinical exome, hereditary cancer panels, and paired DNA and RNA genetic testing. As a committed team of experts, we are equipped with powerful technologies and stand by ready to develop custom assays to meet your specific criteria, as if it were family.
Products